Loading...

Haw Par Corporation Limited

HAWPY•PNK
Healthcare
Drug Manufacturers - General
$54.44
$0.94(1.76%)
U.S. Market opens in 7h 53m

Haw Par Corporation Limited (HAWPY) Stock Overview

Explore Haw Par Corporation Limited’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap3B
P/E Ratio14.49
EPS (TTM)$3.76
ROE0.06%
Fundamental Analysis

AI Price Forecasts

1 Month$59.39
3 Months$59.95
1 Year Target$62.56

HAWPY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Haw Par Corporation Limited (HAWPY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 71.29, suggesting the stock is in an overbought condition. Our forecasting models predict significant price movements, with a 12-month target of $62.56.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 14.49 and a market capitalization of 3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.76%
5-Day Change
1.76%
1-Month Change
1.76%
3-Month Change
11.03%
6-Month Change
7.17%
Year-to-Date (YTD) Change
7.17%
1-Year Change
90.08%
3-Year Change
90.08%
5-Year Change
97.25%
All-Time (Max) Change
111.25%

Contact Information

https://www.hawpar.com
65 6337 9102
No. 03-03 Haw Par Technocentre, Singapore, NaN, 149598

Company Facts

595 Employees
IPO DateApr 3, 2013
CountrySG
Actively Trading

Frequently Asked Questions